Navigation Links
Estrogen May Have Preventive Role in Women's Schizophrenia
Date:8/4/2008

Symptoms, including delusions, hallucinatory behavior, improved with estradiol, study says

MONDAY, Aug. 4 (HealthDay News) -- The estrogen estradiol, when combined with antipsychotic drugs, may help relieve psychotic symptoms in women with schizophrenia, an Australian study suggests.

It included 102 women of child-bearing age with schizophrenia. For 28 days, 56 of the women received 100 micrograms of estradiol daily via a skin patch, while the other 46 received a placebo via a skin patch.

The women's psychotic symptoms, including delusions and hallucinatory behavior, were assessed weekly, and those taking estradiol showed a greater improvement in symptoms.

The study was published in the August issue of the Archives of General Psychiatry.

Estrogen's neuroprotective and psychoprotective actions may be mediated by a variety of routes, ranging from rapid actions, including antioxidant effects and enhancement of cerebral blood flow and cerebral glucose utilization, to slower, genomic mechanisms, which may include permanent modification of neural circuits, the study authors wrote.

The lack of effect for negative symptoms is consistent with literature reporting that negative symptoms are less responsive to treatment than other symptoms of schizophrenia. It is possible that longer-term treatment is required for negative symptoms to respond to treatment. Alternatively, brain regions implicated in negative symptoms may be less responsive to gonadal hormone effects.

The study authors said estrogen may have a preventive role in women with schizophrenia who have childbirth- or menopause-related hormonal changes known to cause a deterioration of their condition.

"Estrogen treatment is a promising new area for future treatment of schizophrenia and potentially for other severe mental illnesses," they concluded.

More information

Mental Health America has more about schizophrenia.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Aug. 4, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Team discovers new inhibitors of estrogen-dependent breast cancer cells
2. Estrogen therapy helps or hurts the brain depending on reproductive status
3. Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women
4. Previously unseen switch regulates breast cancer response to estrogen
5. Estrogen therapy increases benign breast disease risk
6. Estrogen Supplements May Raise Odds of Benign Breast Disease
7. New study finds adverse effects of estrogen replacement therapy are related to the dose
8. Mitochondria play role in pathogenesis of AD and estrogen-induced neuroprotection
9. Estrogen Levels in Blood Predict Breast Cancers Return
10. Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
11. Gene May Influence Breast Cancer-Estrogen Link
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September ... Washington, D.C. offering free MRI brain scans to the public.Where:  ... will be parked at 501 K Street NW, Washington, D.C.What:BTF brings its ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly and ... actions to streamline operations to more efficiently focus ... its cost structure. Global workforce reductions, including those ... expected to impact approximately 3,500 positions. ... expects annualized savings of approximately $500 million that ...
(Date:9/7/2017)... 7, 2017 NuvoAir (formerly called Pond ... today a partnership with Novartis Pharma AG to distribute NuvoAir,s ... as the leading mobile spirometry platform and Novartis, commitment to ... ... ...
Breaking Medicine Technology: